poloxalene has been researched along with niclosamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Budillon, A; Caetano, W; Hioka, N; Milone, MR; Pagliara, V; Pellosi, DS; Pucci, B; Quaglia, F; Russo, A; Russo, G; Ungaro, F | 1 |
1 other study(ies) available for poloxalene and niclosamide
Article | Year |
---|---|
Biotin-targeted Pluronic(®) P123/F127 mixed micelles delivering niclosamide: A repositioning strategy to treat drug-resistant lung cancer cells.
Topics: A549 Cells; Animals; Antineoplastic Agents; Biotin; Cell Survival; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Mice; Micelles; Niclosamide; NIH 3T3 Cells; Poloxalene; Poloxamer; Ribosomal Protein L3 | 2016 |